V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009394 | 270005578 | 1.79 | 70.9 | Palliative (P) | 2013-07-04 | 2013-08-04 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 270018222 | CETUXIMAB + RT |
| 270009395 | 270012763 | 1.72 | 74 | Palliative (P) | 2015-06-18 | 2015-07-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 270018227 | CAPECITABINE + IRINOTECAN |
| 270009396 | 270005579 | 1.62 | 69.2 | Palliative (P) | 2015-02-22 | 2015-03-20 | Capecitabine + Cisplatin | N | N | 270018236 | CHLORAMBUCIL |
| 270009397 | 270005579 | null | 64 | Palliative (P) | 2017-01-09 | 2017-01-12 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270018236 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009398 | 270005580 | 1.56 | 53.9 | Palliative (P) | null | 2014-12-27 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | Y | 270018243 | CETUXIMAB + IRINOTECAN + MDG |
| 270009399 | 270005580 | null | 69.5 | null | 2017-11-14 | 2017-11-29 | CARBOPLATIN + RT | N | N | 270018243 | GEMCARBO |
| 270009400 | 270005581 | 1.73 | 143.8 | null | 2016-11-29 | 2016-12-07 | EOX | N | N | 270018255 | CARBOPLATIN + ETOPOSIDE |
| 270009401 | 270005582 | null | null | Curative (C) | null | 2014-02-04 | CAP + RT | 99 | null | 270018258 | CETUXIMAB |
| 270009402 | 270005582 | 1.8 | 82.6 | Neo-adjuvant (N) | 2014-12-15 | 2014-12-27 | GemCarbo Days 1+8 | N | N | 270018258 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009403 | 270015995 | 1.8 | 108 | Not known (9) | 2014-05-04 | 2014-05-18 | IRINOTECAN + MDG + PANITUMUMAB | N | Y | 270018261 | OXALIPLATIN |
| 270009404 | 270017831 | null | 88.5 | Curative (C) | 2016-01-30 | 2016-01-31 | CARBOPLATIN + RT | N | null | 270018269 | CETUXIMAB + MDG |
| 270009405 | 270005583 | 1.84 | 68.7 | Palliative (P) | 2017-09-13 | 2017-10-12 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270018271 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270009406 | 270005584 | 1.55 | 42.7 | Palliative (P) | 2014-03-14 | 2014-03-20 | Cetuximab + Radiotherapy Maint | 02 | N | 270018276 | CETUXIMAB + IRINOTECAN |
| 270009407 | 270005585 | 1.88 | 66 | Not known (9) | 2014-04-23 | 2014-05-10 | IRINOTECAN + MDG + PANITUMUMAB | 2 | N | 270018284 | CAPECITABINE + IRINOTECAN |
| 270009408 | 270005586 | null | null | Neo-adjuvant (N) | 2014-09-30 | 2014-10-14 | CARBOPLATIN + RT | N | N | 270018285 | CARBOPLATIN |
| 270009409 | 270005587 | 1.59 | 58 | Palliative (P) | 2018-03-11 | 2018-03-11 | Bevacizumab 5mg/kg | 02 | N | 270018295 | GEMCARBO |
| 270009410 | 270012767 | 1.72 | 95 | Curative (C) | 2015-05-17 | 2015-06-05 | CARBOPLATIN + RT | N | N | 270018296 | CETUXIMAB + RT |
| 270009411 | 270012767 | null | null | Curative (C) | 2014-01-27 | 2014-02-11 | CARBOPLATIN + PACLITAXEL + RT | N | N | 270018296 | FLUOROURACIL + MITOMYCIN |
| 270009412 | 270012767 | 1.7 | 96 | Curative (C) | 2015-01-03 | 2015-01-27 | MITOMYCIN | N | N | 270018296 | CARBOPLATIN + RT |
| 270009413 | 270012767 | 1.75 | 82.3 | Palliative (P) | 2015-05-23 | 2015-05-30 | Carboplatin AUC 2 - 5 | 02 | N | 270018296 | CETUXIMAB + IRINOTECAN + MDG |
| 270009414 | 270019473 | 0 | 83.2 | Palliative (P) | 2018-04-18 | 2018-04-18 | CETUXIMAB + RT | 2 | N | 270018317 | CETUXIMAB |
| 270009415 | 270019473 | 1.62 | 53.4 | Palliative (P) | 2017-12-11 | 2017-12-18 | GemCarbo Days 1+8 | N | N | 270018317 | CARBOPLATIN |
| 270009416 | 270005588 | 1.72 | 46 | Palliative (P) | 2016-12-18 | 2016-12-30 | Cetuximab + FOLFIRI cycle1 | 2 | N | 270018327 | CARBOPLATIN + ETOPOSIDE |
| 270009417 | 270005589 | 1.75 | null | Palliative (P) | 2014-07-30 | 2014-08-04 | Cetuximab + FOLFIRI cycle1 | N | N | 270018331 | CETUXIMAB + IRINOTECAN + MDG |
| 270009418 | 270005590 | 1.74 | null | null | null | 2016-02-09 | CETUXIMAB + OXALIPLATIN + MDG | null | null | 270018338 | CARBO + FLUOROURACIL |
| 270009419 | 270012768 | 1.6 | 52 | Palliative (P) | 2014-06-22 | 2014-07-03 | Carboplatin + Etoposide IV 3 day | N | N | 270018361 | CARBO + FLUOROURACIL |
| 270009420 | 270012768 | 1.67 | 70.6 | Adjuvant (A) | 2015-05-07 | 2015-05-07 | CAPECITABINE + CARBOPLATIN | N | null | 270018361 | GEMCARBO |
| 270009421 | 270005591 | 1.66 | 61.4 | Neo-adjuvant (N) | 2014-12-03 | 2014-12-21 | NIVOLUMAB | N | N | 270018385 | CARBOPLATIN + PEMETREXED |
| 270009422 | 270005592 | 1.68 | 49.4 | Adjuvant (A) | 2015-04-01 | 2015-04-02 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 270018386 | RALTITREXED |
| 270009423 | 270012769 | null | 84.1 | Curative (C) | null | 2013-05-19 | Carboplatin AUC 6 - 10 | null | null | 270018394 | CARBOPLATIN |
| 270009424 | 270005593 | 1.58 | 65 | Palliative (P) | 2014-12-09 | 2014-12-14 | Carboplatin AUC 6 - 10 | Y | N | 270018398 | CETUXIMAB + RT |
| 270009425 | 270005593 | 1.73 | 65.4 | Curative (C) | 2017-08-02 | 2017-08-09 | Carboplatin AUC 2 - 5 | 2 | N | 270018398 | CISPLATIN + GEMCITABINE |
| 270009426 | 270005593 | 1.82 | null | Palliative (P) | 2014-02-08 | 2014-02-22 | Irinotecan 14day | null | null | 270018398 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009427 | 270005593 | 1.84 | 118.55 | Curative (C) | 2014-11-22 | 2014-11-22 | Cisplatin + Vinorelbine (IV) | 02 | N | 270018398 | CETUXIMAB + RT |
| 270009428 | 270005594 | 0 | 90 | Adjuvant (A) | 2016-07-08 | 2016-07-22 | Folfirinox | 2 | null | 270018424 | ENZALUTAMIDE |
| 270009429 | 270005595 | 1.66 | null | Neo-adjuvant (N) | 2017-05-02 | 2017-05-09 | CARBOPLATIN + RT | N | N | 270018427 | SCOT TRIAL |
| 270009430 | 270005595 | null | null | Palliative (P) | 2014-05-13 | 2014-05-19 | Carboplatin + Etoposide iv&po | Y | N | 270018427 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009431 | 270005595 | 1.61 | 73 | Neo-adjuvant (N) | 2014-05-22 | 2014-06-18 | Cetuximab + Radiotherapy Load | N | N | 270018427 | CETUXIMAB + RT |
| 270009432 | 270005596 | 1.78 | 73 | Palliative (P) | 2016-03-04 | 2016-03-14 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270018453 | CARBOPLATIN + ETOPOSIDE |
| 270009433 | 270005597 | 1.83 | 74 | Curative (C) | 2014-07-27 | 2014-07-27 | BCG Intravesical | 02 | N | 270018455 | CETUXIMAB |
| 270009434 | 270005598 | 1.7 | 86 | Neo-adjuvant (N) | 2013-02-11 | 2013-03-05 | Capecitabine (14 day) + Irinotecan | 2 | N | 270018470 | BEVACIZUMAB + CAPECITABINE |
| 270009435 | 270005599 | 1.56 | 54.9 | Adjuvant (A) | null | 2013-09-05 | IRINOTECAN + MDG + PANITUMUMAB | null | null | 270018473 | CAPECITABINE + IRINOTECAN |
| 270009437 | 270005601 | 1.63 | 85 | Curative (C) | 2015-01-20 | 2015-02-17 | CAPECITABINE + MITOMYCIN + RT | N | Y | 270018484 | CETUXIMAB |
| 270009438 | 270005602 | 1.82 | 77 | null | 2017-05-03 | 2017-05-10 | Cetuximab + Radiotherapy Load | N | N | 270018489 | CAPECITABINE + CISPLATIN |
| 270009439 | 270005603 | 1.74 | 69 | Curative (C) | 2014-07-25 | 2014-07-25 | Carbo F | N | N | 270018505 | ECX |
| 270009440 | 270012772 | null | null | Curative (C) | null | 2014-05-14 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 270018509 | CARBO + FLUOROURACIL |
| 270009441 | 270005604 | 1.85 | null | Palliative (P) | 2013-03-01 | 2013-03-23 | Fluorouracil + Folinic + RT Bossett | N | N | 270018511 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009442 | 270005605 | 1.79 | 69.5 | Palliative (P) | 2018-06-07 | 2018-06-24 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 270018520 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009443 | 270005606 | 1.67 | 69.4 | Palliative (P) | 2014-08-10 | 2014-08-15 | CETUXIMAB | 02 | N | 270018521 | CARBOPLATIN + RT |
| 270009444 | 270005607 | null | 81.6 | Neo-adjuvant (N) | 2014-09-29 | 2014-09-29 | GEMCARBO | N | N | 270018537 | BEVACIZUMAB + CAPE + OXALIPLATIN |